Alterity Therapeutics Limited Interest Expense 2011-2026 | ATHE

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Alterity Therapeutics Limited

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.28 K	1.3 K	3.88 K	-	-	-	-	-	-	-	-	-

All numbers in AUD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.88 K	1.3 K	2.49 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Black Diamond Therapeutics BDTX	6.92 M	$ 2.38	-3.64 %	$ 131 M	USA
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Alector ALEC	13.2 M	$ 2.1	-13.79 %	$ 216 M	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	685 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	3.96 M	-	-	$ 269 M	USA
Altimmune ALT	48 K	$ 4.2	-2.67 %	$ 298 M	USA
Arena Pharmaceuticals ARNA	4.16 M	-	-6.81 %	$ 3.04 B	USA
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	103 K	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	3.02 M	-	-16.42 %	$ 249 M	USA
AVEO Pharmaceuticals AVEO	1.6 M	-	-	$ 521 M	USA
Atreca BCEL	3 K	-	-11.76 %	$ 5.79 M	USA
Apellis Pharmaceuticals APLS	-133 K	$ 20.61	-1.67 %	$ 2.6 B	USA
Agenus AGEN	1.26 M	$ 3.33	-	$ 1.19 M	USA
Agios Pharmaceuticals AGIO	1.96 M	$ 28.87	-4.5 %	$ 1.67 B	USA
bluebird bio BLUE	16.4 M	-	-	$ 546 M	USA
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA